Related Experiment Video

Updated: Aug 16, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Immunotherapy for gynaecological malignancies

George Coukos1, Jose R Conejo-Garcia, Richard B S Roden

  • 1Abramson Cancer Research Institute, Center for Research on Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA 19104, USA.

Expert Opinion on Biological Therapy
|August 27, 2005
PubMed

Insights

Novel immunotherapies show promise for preventing and treating cervical and ovarian cancers. Targeting human papillomavirus (HPV) in cervical cancer and exploiting the immunogenicity of ovarian cancer are key strategies.

Area of Science:

  • Gynecologic Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Gynaecological malignancies (excluding breast cancer) result in ~25,000 US deaths annually, necessitating innovative treatments.
  • Cervical cancer shows promise for immunotherapy due to human papillomavirus (HPV) xenoantigens recognized by the immune system.
  • Emerging evidence suggests ovarian cancer is also immunogenic, making it a viable target for immunotherapy.

Purpose of the Study:

  • To review the principles and challenges of immunotherapy for cervical and ovarian cancers.
  • To provide an expert assessment of current and future directions in gynecologic cancer immunotherapy.

Main Methods:

  • Literature review focusing on immunotherapy principles and applications.
  • Analysis of preclinical and clinical data for HPV-targeted therapies in cervical cancer.
  • Evaluation of immunogenicity and immunotherapy approaches for ovarian cancer.

Main Results:

  • Targeting HPV xenoantigens has demonstrated significant promise in preclinical and clinical settings for cervical cancer.
  • Ovarian cancer's immunogenicity supports its potential for successful immunotherapy interventions.
  • The review synthesizes current knowledge and highlights areas for future research.

Conclusions:

  • Immunotherapy represents a promising avenue for managing cervical and ovarian cancers.
  • Further research and clinical studies are essential to optimize immunotherapeutic strategies for these malignancies.
  • Addressing the challenges in gynecologic cancer immunotherapy is crucial for improving patient outcomes.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...